Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
The American Journal of Pathology
|
May 22, 2010
PDGF-C mediates glomerular capillary repair
Peter Boor, Claudia R C van Roeyen, Uta Kunter, et al.
Kidney International
|
August 26, 2011
Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D
Claudia R C van Roeyen, Frank Eitner, Peter Boor, et al.
Journal of the American Society of Nephrology : JASN
|
March 29, 2007
Complement C5 mediates experimental tubulointerstitial fibrosis
Peter Boor, Andrzej Konieczny, Luigi Villa, et al.
Plos One
|
April 1, 2015
Increased cerebral water content in hemodialysis patients
Kathrin Reetz, Zaheer Abbas, Ana Sofia Costa, et al.
International Journal of Molecular Sciences
|
September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats
Jan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.
Journal of the American Society of Nephrology : JASN
|
October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy
Thomas Rauen, Christina Fitzner, Frank Eitner, et al.
Journal of the American Society of Nephrology : JASN
|
August 26, 2003
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis
Tammo Ostendorf, Claudia R C van Roeyen, Jeffrey D Peterson, et al.
The New England Journal of Medicine
|
December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
Thomas Rauen, Frank Eitner, Christina Fitzner, et al.
The American Journal of Pathology
|
July 29, 2015
Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis
Peter Boor, Janka Bábíčková, Floor Steegh, et al.
Kidney International
|
May 26, 2020
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy
Thomas Rauen, Stephanie Wied, Christina Fitzner, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
The American Journal of Pathology
|
May 22, 2010
PDGF-C mediates glomerular capillary repair
Peter Boor, Claudia R C van Roeyen, Uta Kunter, et al.
Kidney International
|
August 26, 2011
Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D
Claudia R C van Roeyen, Frank Eitner, Peter Boor, et al.
Journal of the American Society of Nephrology : JASN
|
March 29, 2007
Complement C5 mediates experimental tubulointerstitial fibrosis
Peter Boor, Andrzej Konieczny, Luigi Villa, et al.
Plos One
|
April 1, 2015
Increased cerebral water content in hemodialysis patients
Kathrin Reetz, Zaheer Abbas, Ana Sofia Costa, et al.
International Journal of Molecular Sciences
|
September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats
Jan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.
Journal of the American Society of Nephrology : JASN
|
October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy
Thomas Rauen, Christina Fitzner, Frank Eitner, et al.
Journal of the American Society of Nephrology : JASN
|
August 26, 2003
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis
Tammo Ostendorf, Claudia R C van Roeyen, Jeffrey D Peterson, et al.
The New England Journal of Medicine
|
December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
Thomas Rauen, Frank Eitner, Christina Fitzner, et al.
The American Journal of Pathology
|
July 29, 2015
Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis
Peter Boor, Janka Bábíčková, Floor Steegh, et al.
Kidney International
|
May 26, 2020
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy
Thomas Rauen, Stephanie Wied, Christina Fitzner, et al.
Page
of 9